← Eichor
Condition: Infection By Human Papilloma Virus Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Infection By Human Papilloma Virus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vac
Phase 4 · 1 location(s) · Xiamen Innovax Biotech Co., Ltd · NCT07668271Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05918510Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06055868Point of Care - Triage and Treatment for Cervical Pre-cancer
NA · 1 location(s) · Basic Health International, Inc. · NCT07461818A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Phase N/A · 1 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT05774561The Women's Screening and Self-Testing Program (PROMETA) Study
NA · 1 location(s) · Tulane University · NCT06810739Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06327568A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
Phase 1/Phase 2 · 2 location(s) · Cellid Co., Ltd. · NCT06797986Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Phase 2 · 5 location(s) · Vastra Gotaland Region · NCT06793410Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neopla
NA · 1 location(s) · PCK Marine Hospital in Gdynia · NCT06574087A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants W
Phase 1/Phase 2 · 32 location(s) · Marengo Therapeutics, Inc. · NCT05592626Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
NA · 1 location(s) · Karolinska Institutet · NCT07275333Self-sampling for Non-attenders to Cervical Cancer Screening
NA · 1 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT04226313Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NA · 1 location(s) · University Hospital, Toulouse · NCT04901351The Organ Transplant Recipient HPV and Skin Cancer Study
Phase N/A · 3 location(s) · Merete Haedersdal · NCT05284877Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NA · 3 location(s) · Qurasense · NCT07281599Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
NA · 18 location(s) · National Cancer Institute (NCI) · NCT07281430HPV Vaccine, Imiquimod, and Metformin Combination Trial
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT06686043Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05027776PopSci CHW4CervixHealth
NA · 1 location(s) · Thomas Jefferson University · NCT07336134Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Phase N/A · 8 location(s) · International Vaccine Institute · NCT06129253Natural History Study of GATA2 Deficiency and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01905826Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NA · 5 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT07033091
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.